Lee JS - Search Results

1

Retinoic acid receptor-beta as a prognostic indicator in stage I non-small-cell lung cancer.

Khuri FR, Lotan R, Kemp BL, Lippman SM, Wu H, Feng L, Lee JJ, Cooksley CS, Parr B, Chang E, Walsh GL, Lee JS, Hong WK, Xu XC. Khuri FR, et al. Among authors: lee js, lee jj. J Clin Oncol. 2000 Aug;18(15):2798-804. doi: 10.1200/JCO.2000.18.15.2798. J Clin Oncol. 2000. PMID: 10920126

2

Phase II study of combination therapy with high-dose cisplatin, etoposide, and mitomycin in patients with advanced non-small-cell lung cancer.

Shin DM, Dhingra HM, Lee JS, Fossella FV, Murphy WK, Hong WK. Shin DM, et al. Among authors: lee js. Am J Clin Oncol. 1992 Jun;15(3):194-9. doi: 10.1097/00000421-199206000-00003. Am J Clin Oncol. 1992. PMID: 1317094 Clinical Trial.

3

The incidence of second primary tumors in long-term survivors of small-cell lung cancer.

Heyne KH, Lippman SM, Lee JJ, Lee JS, Hong WK. Heyne KH, et al. Among authors: lee js, lee jj. J Clin Oncol. 1992 Oct;10(10):1519-24. doi: 10.1200/JCO.1992.10.10.1519. J Clin Oncol. 1992. PMID: 1328547

4

Study of multidrug resistance (mdr1) gene in non-small-cell lung cancer.

Shin HJ, Lee JS, Hong WK, Shin DM. Shin HJ, et al. Among authors: lee js. Anticancer Res. 1992 Mar-Apr;12(2):367-70. Anticancer Res. 1992. PMID: 1374598

5

Primary chemotherapy of brain metastasis in small-cell lung cancer.

Lee JS, Murphy WK, Glisson BS, Dhingra HM, Holoye PY, Hong WK. Lee JS, et al. J Clin Oncol. 1989 Jul;7(7):916-22. doi: 10.1200/JCO.1989.7.7.916. J Clin Oncol. 1989. PMID: 2544685 Clinical Trial.

6

Anti-retinoic acid (RA) antibody binding to human premalignant oral lesions, which occurs less frequently than binding to normal tissue, increases after 13-cis-RA treatment in vivo and is related to RA receptor beta expression.

Xu XC, Zile MH, Lippman SM, Lee JS, Lee JJ, Hong WK, Lotan R. Xu XC, et al. Among authors: lee js, lee jj. Cancer Res. 1995 Dec 1;55(23):5507-11. Cancer Res. 1995. PMID: 7585623

7

Expression of p53 oncoprotein in non-small-cell lung cancer: a favorable prognostic factor.

Lee JS, Yoon A, Kalapurakal SK, Ro JY, Lee JJ, Tu N, Hittelman WN, Hong WK. Lee JS, et al. Among authors: lee jj. J Clin Oncol. 1995 Aug;13(8):1893-903. doi: 10.1200/JCO.1995.13.8.1893. J Clin Oncol. 1995. PMID: 7636531

8

Suppression of retinoic acid receptor-beta in premalignant oral lesions and its up-regulation by isotretinoin.

Lotan R, Xu XC, Lippman SM, Ro JY, Lee JS, Lee JJ, Hong WK. Lotan R, et al. Among authors: lee js, lee jj. N Engl J Med. 1995 May 25;332(21):1405-10. doi: 10.1056/NEJM199505253322103. N Engl J Med. 1995. PMID: 7723796 Free article.

9

Phase I evaluation of all-trans retinoic acid with and without ketoconazole in adults with solid tumors.

Lee JS, Newman RA, Lippman SM, Fossella FV, Calayag M, Raber MN, Krakoff IH, Hong WK. Lee JS, et al. J Clin Oncol. 1995 Jun;13(6):1501-8. doi: 10.1200/JCO.1995.13.6.1501. J Clin Oncol. 1995. PMID: 7751898 Clinical Trial.

10

Phase II study of docetaxel for recurrent or metastatic non-small-cell lung cancer.

Fossella FV, Lee JS, Murphy WK, Lippman SM, Calayag M, Pang A, Chasen M, Shin DM, Glisson B, Benner S, et al. Fossella FV, et al. Among authors: lee js. J Clin Oncol. 1994 Jun;12(6):1238-44. doi: 10.1200/JCO.1994.12.6.1238. J Clin Oncol. 1994. PMID: 7911160 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14,715 results

Search Page

Filters